MedTrace Logo

Translating Research Into Practice: Patient Navigation for Breast Cancer

NCT03514433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1725

Last updated 2024-07-03

Study results available
· View outcomes & findings →

Summary

The TRIP Project aims to overcome barriers to widespread implementation and dissemination of evidence-based practices that will improve the delivery of guideline-concordant care to vulnerable women with breast cancer. To accomplish this goal the study team will create (a) regional patient registries; (b) systematic screening for social barriers to care with a personalized referral plan; and (c) patient navigation services that integrate into one model of care to improve the quality and effectiveness of care delivery, for minority and/or low-income women with breast cancer in Boston.

Conditions

  • Cancer, Breast

Interventions

OTHER

TRIP Patient Navigation Intervention

The TRIP intervention will replace the current standard of care at the 5 participating hospitals once it is rolled out on-site. Any TRIP eligible patients receiving patient navigation services over the course of the study will receive the enhanced services.

Sponsors & Collaborators

  • Boston University

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • Beth Israel Deaconess Medical Center

    collaborator OTHER

  • Tufts Medical Center

    collaborator OTHER

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Tracy Battaglia, MD., MPH · Boston Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-05
Primary Completion
2023-09-22
Completion
2023-09-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03514433 on ClinicalTrials.gov